Nomination Committee for Vimian’s 2027 Annual General Meeting

VIMIANRegulatoriskt pressmeddelande2026-09-17 10:00

The Nomination Committee for Vimian Group has been appointed.

Vimian’s Nomination Committee for the 2027 Annual General Meeting has been appointed based on the ownership structure as of 31 August 2026.

The Nomination Committee comprises the following members:

Håkan Håkansson, Fidelio Capital

Suzanne Sandler, Handelsbanken Fonder

Henri de la Perraudière, Anicom Gestion

Magnus Welander, Chairman of the Board

Chairman of the Nomination Committee will be appointed at the Nomination Committee’s first meeting.

The Annual General Meeting of Vimian Group will be held on 28 April 2027. Shareholders who would like to submit proposals to the Nomination Committee for the 2027 Annual General Meeting can submit such via email to generalmeetings@vimian.com no later than 8 February 2026.

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches veterinary clinics and laboratories in over 80 markets, has 1,300 employees and annual revenues of approximately EUR 425 million. For more information, please visit: www.vimian.com.